“There is some early, though not yet vetted, evidence to suggest that patients with COVID-19 may have characteristic features of lymphopenia and other leukocyte abnormalities in the peripheral blood. At initial presentation, when it is important to keep patients with suspected COVID-19 isolated until they have been tested, an early indicator such as a suggestive lymphopenia profile could prove valuable in addition to other criteria for managing infection control procedures and making rapid decisions about whom to prioritize or isolate for further assessment.”
Newsletters
Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.
